Treatment of chronic plantar fasciitis with Botulinum toxin A: preliminary clinical results.
Standard
Treatment of chronic plantar fasciitis with Botulinum toxin A: preliminary clinical results. / Placzek, Richard; Deuretzbacher, Georg; Meiss, A Ludwig.
in: CLIN J PAIN, Jahrgang 22, Nr. 2, 2, 2006, S. 190-192.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Treatment of chronic plantar fasciitis with Botulinum toxin A: preliminary clinical results.
AU - Placzek, Richard
AU - Deuretzbacher, Georg
AU - Meiss, A Ludwig
PY - 2006
Y1 - 2006
N2 - Based on recent results in chronic lateral epicondylitis we decided to investigate the efficacy of Botulinum toxin A (BTX-A) for treatment of chronic therapy resistant plantar fasciitis. Nine patients with an average duration of symptoms of 14 months and at least two prior conservative treatments received a one injection of 200 units of BTX-A (Dysport) subfascially into the painful area. The patients documented pain at rest and during weight-bearing after 2, 6, 10 and 14 weeks by a visual analogue scale. A significant reduction of pain during weight-bearing to about 50% was seen 6 weeks after injection. The effect was still present at the latest follow-up of 14 weeks. Similarly, the pain at rest was reduced to less than half of the initial value at any follow-up. All patients were satisfied and did not require further treatment.
AB - Based on recent results in chronic lateral epicondylitis we decided to investigate the efficacy of Botulinum toxin A (BTX-A) for treatment of chronic therapy resistant plantar fasciitis. Nine patients with an average duration of symptoms of 14 months and at least two prior conservative treatments received a one injection of 200 units of BTX-A (Dysport) subfascially into the painful area. The patients documented pain at rest and during weight-bearing after 2, 6, 10 and 14 weeks by a visual analogue scale. A significant reduction of pain during weight-bearing to about 50% was seen 6 weeks after injection. The effect was still present at the latest follow-up of 14 weeks. Similarly, the pain at rest was reduced to less than half of the initial value at any follow-up. All patients were satisfied and did not require further treatment.
M3 - SCORING: Zeitschriftenaufsatz
VL - 22
SP - 190
EP - 192
JO - CLIN J PAIN
JF - CLIN J PAIN
SN - 0749-8047
IS - 2
M1 - 2
ER -
